• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Better prostate cancer care for highly educated

Bioengineer by Bioengineer
March 26, 2024
in Health
Reading Time: 3 mins read
0
Ola Bratt
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Men with advanced degrees and higher income are more likely to receive certain care and treatment for prostate cancer. Their risk of dying from the disease is also lower than for men with low income and education level. These are the findings of a study conducted at the University of Gothenburg.

Ola Bratt

Credit: Photo by Emelie Ljunggren

Men with advanced degrees and higher income are more likely to receive certain care and treatment for prostate cancer. Their risk of dying from the disease is also lower than for men with low income and education level. These are the findings of a study conducted at the University of Gothenburg.

Behind the study, published in International Journal of Cancer, is a group of researchers from Sahlgrenska Academy at the University of Gothenburg, Karolinska Institutet, Uppsala University and Umeå University.

The foundation for the study was drawn from the research database PCBaSe, which contains data from several national registries, including the National Prostate Cancer Registry. The study included data on more than 32,000 men in total. What was analyzed was the relationship between income and education, and several important measures of prostate cancer care.

Clear links to education and income

The results clearly show that education and income affect the evaluation and treatment of men with suspected or newly diagnosed prostate cancer.

Advanced degrees and higher income were associated with an increased likelihood of having an MRI scan for evaluation of suspected prostate cancer, during the 2018 to 2020 implementation phase. The proportion completing this examination was 47%, compared to 35% in the groups with shorter education and lower income.

Those with more advanced degrees or higher income were also more likely to receive curative treatment for severe prostate cancer that had not spread. The percentages ranged from 89% to 75% in the different groups.

Similar differences were found for repeat prescription of erection-boosting tablets after prostate cancer surgery. The proportion of men receiving this rehabilitation varied between 44 and 52%, depending on education and income.

The proportion of men with a fatal outcome of a serious prostate cancer that had not spread was clearly higher for men with lower education or income than for men with advanced degrees or higher income. For low income versus high, the proportions that died were 12.5% and 8.5%, respectively. The differences were mainly due to that men with a short education and lower income had a more severe disease at diagnosis, not to that they received poorer care after diagnosis.

Possible ways to reduce inequality

“Although Sweden is relatively socioeconomically equal, the results show differences in cancer care according to income and education. In an international comparison, the differences are quite small,” says Ola Bratt, Professor of Clinical Cancer Epidemiology at the University of Gothenburg, Consultant Urologist at Sahlgrenska University Hospital, and the principal investigator of the study.

The researchers see organized prostate cancer testing as a possible way to improve equality in diagnosis. Ulf Strömberg is Adjunct Professor of Epidemiological Methodology at the University of Gothenburg, an epidemiologist at Region Kronoberg, and one of the researchers conducting the study:

“There are many indications that efforts to increase equality are mainly needed in diagnostics so that prostate cancer can be detected at an earlier stage in men from socioeconomically vulnerable groups,” he says.



Journal

International Journal of Cancer

DOI

10.1002/ijc.34932

Method of Research

Observational study

Subject of Research

People

Article Title

Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

Article Publication Date

25-Mar-2024

Share12Tweet8Share2ShareShareShare2

Related Posts

Nanomedicine: A New Frontier in Targeting Metastasis

September 12, 2025

New Phthalide Compounds Show Promise as Antifungal Agents

September 12, 2025

Overcoming Challenges in Treating Severe Eating Disorders

September 12, 2025

Necroptosis Creates Soluble Tissue Factor Driving Thrombosis

September 12, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nanomedicine: A New Frontier in Targeting Metastasis

Fungal Effector Undermines Maize Immunity by Targeting ZmLecRK1

New Phthalide Compounds Show Promise as Antifungal Agents

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.